Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 450 of 451 entries
View as:

Comparing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) Using Mitomycin-C Versus Melphalan for Colorectal Peritoneal Carcinomatosis

Phase: N/A Priority: Normal
NCT ID: NCT03073694 Org: User:
Start: 07/14/17 End: 07/31/25 Due: 07/31/26

Plasma Neurofilament Light and Its Relationship With Omega-3 Status and Soccer Heading in Women Soccer Players

Phase: N/A Priority: Normal
NCT ID: NCT05457023 Org: User:
Start: 07/28/22 End: 11/09/23 Due: 11/09/24

Erlotinib Plus Chemotherapy for Treatment of Triple Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00491816 Org: User:
Start: 07/31/07 End: 12/31/17 Due: 12/31/18

Changing Talk Online (CHATO) Study

Phase: N/A Priority: Normal
NCT ID: NCT03849937 Org: User:
Start: 09/03/19 End: 08/31/20 Due: 08/31/21

Multi-day Doses in Prevention of Nausea and Emesis

Phase: N/A Priority: Normal
NCT ID: NCT00600353 Org: User:
Start: 10/31/07 End: 01/31/10 Due: 01/31/11

Oxaliplatin and Docetaxel Followed by Cetuximab for Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00591149 Org: User:
Start: 06/30/07 End: 04/30/12 Due: 04/30/13

Rural Engagement in Primary Care for Optimizing Weight Reduction

Phase: N/A Priority: Normal
NCT ID: NCT02456636 Org: User:
Start: 02/15/16 End: 12/30/19 Due: 12/30/20

Pharmacogenomic Study in Patients of Lung, Colorectal and Head/Neck Cancers Receiving Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00442520 Org: User:
Start: 02/28/06 End: 09/30/08 Due: 09/30/09

The Purpose of This Trial is to Determine if Regorafenib Plus Durvalumab (MEDI4736) is Safe and Effective in Treatment of Chemo Refractory Advanced Biliary Tract Cancers

Phase: N/A Priority: Normal
NCT ID: NCT04781192 Org: User:
Start: 03/22/22 End: 12/31/25 Due: 12/31/26

ALS Study Determining Various Biomarkers and Strength Comparison After Exercise

Phase: N/A Priority: Normal
NCT ID: NCT03201991 Org: User:
Start: 05/01/17 End: 04/18/18 Due: 04/18/19

Lifileucel With Reduced Dose Fludarabine/Cyclophosphamide Lymphodepletion and Interleukin-2 for the Treatment of Patients With Unresectable or Metastatic Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT06151847 Org: User:
Start: 12/21/23 End: 11/27/25 Due: 11/27/26

Motor Outcomes to Validate Evaluations in Pediatric FSHD (MOVE Peds)

Phase: N/A Priority: Normal
NCT ID: NCT06847282 Org: User:
Start: 05/22/25 End: 05/31/28 Due: 05/31/29

Study of Open Label Losartan in COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT04335123 Org: User:
Start: 04/04/20 End: 08/17/20 Due: 08/17/21

Qigong Exercise May Benefit Patients With Fibromyalgia

Phase: N/A Priority: Normal
NCT ID: NCT01333566 Org: User:
Start: 07/31/09 End: 02/28/15 Due: 02/28/16

Efficacy of Platelet Enriched Plasma in Preventing Surgery for Patients With Chronic Tympanic Membrane Perforation

Phase: N/A Priority: Normal
NCT ID: NCT03837665 Org: User:
Start: 05/02/18 End: 10/29/19 Due: 10/29/20

Assessing a Dose-Response Relationship of Hydralazine and Its Effects on DNA Methyltransferase 1 in Polycystic Kidney Disease Patients

Phase: N/A Priority: Normal
NCT ID: NCT03423810 Org: User:
Start: 04/23/18 End: 01/30/20 Due: 01/30/21

Peripheral Blood Stem Cell (PBSC) Mobilization in Patients With Relapsed Lymphoma Treated With Bendamustine

Phase: N/A Priority: Normal
NCT ID: NCT01022021 Org: User:
Start: 01/31/10 End: 08/31/15 Due: 08/31/16

Blueberry Intervention Study for Brain Aging

Phase: N/A Priority: Normal
NCT ID: NCT05024916 Org: User:
Start: 06/01/22 End: 10/03/24 Due: 10/03/25

Tranexamic Acid in Radical Resection and Endoprosthetic Reconstruction

Phase: N/A Priority: Normal
NCT ID: NCT04347122 Org: User:
Start: 01/28/20 End: 08/18/23 Due: 08/18/24

Lidocaine Infusion Treatment for Subarachnoid Hemorrhage Headaches

Phase: N/A Priority: Normal
NCT ID: NCT06582810 Org: User:
Start: 10/31/24 End: 07/31/28 Due: 07/31/29

Resiliency in Patients Undergoing Radical Cystectomy for Bladder Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06337305 Org: User:
Start: 08/19/20 End: 08/19/23 Due: 08/19/24

Exosomes in Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03874559 Org: User:
Start: 02/13/18 End: 02/01/26 Due: 02/01/27

To Assess Immunogenicity of Coronavirus Disease 2019 (COVID-19) Vaccine in Cancer Patients Receiving Cancer Treatment

Phase: N/A Priority: Normal
NCT ID: NCT04821570 Org: User:
Start: 02/23/21 End: 03/28/25 Due: 03/28/26

Impact of Statin Therapy on Muscle Mitochondrial Function and Aerobic Capacity

Phase: N/A Priority: Normal
NCT ID: NCT03351998 Org: User:
Start: 02/22/18 End: 07/07/23 Due: 07/07/24

COVID-19 Biorepository

Phase: N/A Priority: Normal
NCT ID: NCT04568148 Org: User:
Start: 04/15/20 End: 12/31/25 Due: 12/31/26